Want to see LLY full AI Analyst Report?
Eli Lilly & Co (LLY) Income Statement
Eli Lilly & Co Income Statement
Last quarter (Q3 2026), Eli Lilly & Co's total revenue was $24.40B, an increase of 38.61% from the same quarter last year. In Q3, Eli Lilly & Co's net income was $6.45B. See Eli Lilly & Co’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 65.18B | $ 45.04B | $ 34.12B | $ 28.54B | $ 28.32B | |
| $ 54.13B | $ 36.63B | $ 27.04B | $ 21.91B | $ 21.01B | |
| $ 24.43B | $ 19.59B | $ 16.25B | $ 13.26B | $ 13.07B | |
| Depreciation and Amortization | $ 2.00B | $ 1.77B | $ 1.53B | $ 1.52B | $ 1.55B |
| $ 31.69B | $ 18.81B | $ 8.57B | $ 8.66B | $ 8.04B | |
| $ 29.70B | $ 17.04B | $ 10.79B | $ 8.65B | $ 7.93B | |
| $ -3.96B | $ -4.36B | $ -4.23B | $ -1.85B | $ -1.78B | |
| $ 25.73B | $ 12.68B | $ 6.55B | $ 6.81B | $ 6.16B | |
| $ 20.64B | $ 10.59B | $ 5.24B | $ 6.24B | $ 5.58B | |
| Per Share Metrics | |||||
| Basic EPS | $ 23.07 | $ 11.76 | $ 5.83 | $ 6.57 | $ 5.85 |
| Diluted EPS | $ 22.95 | $ 11.71 | $ 5.80 | $ 6.57 | $ 5.85 |
| Weighted Average Shares Outstanding | 898.00M | 900.61M | 899.38M | 950.18M | 953.65M |
| Weighted Average Shares Outstanding (Diluted) | 898.00M | 904.06M | 903.28M | 950.18M | 953.65M |
Currency in USD
